Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Deoxycytidine Kinase (DCK) Peptide

DCK Reactivité: Mammifères Hôte: Synthetic BP, WB, IHC
N° du produit ABIN936955
  • Antigène Tous les produits DCK
    DCK (Deoxycytidine Kinase (DCK))
    Type de proteíne
    Synthetic
    Origine
    Mammifères
    Source
    • 4
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Séquence
    ATPETCLHRI YLRGRNEEQG IPLEYLEKLH YKHESWLLHR TLKTNFDYLQ
    Attributs du produit
    A synthetic peptide for use as a blocking control in assays to test for specificity of DCK antibody,
    Alternative Names: DCK control peptide, DCK antibody Blocking Peptide, Anti-DCK Blocking Peptide, Deoxycytidine Kinase Blocking Peptide, MGC117410 Blocking Peptide, MGC138632 Blocking Peptide
  • Indications d'application
    Optimal conditions should be determined by the investigator
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20 °C long term.
  • Antigène
    DCK (Deoxycytidine Kinase (DCK))
    Synonymes
    dck Peptide, DCK Peptide, wu:fc15f06 Peptide, zgc:101771 Peptide, dck1 Peptide, deoxycytidine kinase Peptide, deoxycytidine kinase, gene 2 L homeolog Peptide, deoxycytidine kinase, gene 2 Peptide, Deoxycytidine kinase Peptide, deoxycytidine kinase, gene 1 L homeolog Peptide, DCK Peptide, dck Peptide, dck.2.L Peptide, dck.2 Peptide, Dck Peptide, FPV059 Peptide, FPV151 Peptide, dck.1.L Peptide
    Sujet
    Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.
    Poids moléculaire
    30 kDa
Vous êtes ici:
Support technique